1Ceriello A, Johns D, Widel M, et al. Comparison of effect of pioglitazone with metformin or sulfonylurea(monotherapy and combination therapy) on postload glycemia and composite insulin sensitivity index during and oral glucose tolerance test in patients with type 2 diabetes. Diabetes[J]. Diabetes Care 2005;28(2) :266 - 272.
2Groop L C. Insulin resistance: the fundamental trigger of type 2 diabetes[J ]. Diabetes, Obesity & Metabolism 1999 ; 1 (1) : 1 - 7.
3Knowler WC, Barrett - Connor E, Fowler SE, et al. Reductio in the incidence of type 2 diabetes with lifestyle intervention or metformin[J]. N Engl J Med 2002;346(6) :393 - 403.
4Diabetes Prevention Program Research Group. Effects of withdrawal from metformin on the development of diabetes in the diabetes prevention program[J]. diabetes Care 2003 ;26(4) :977 - 980.
9UK Prospective Diabetes Study Group. Effect of intensive blood - glucose control with metformin on complications in overweight patients with type 2 diabetes[J], Lancet 1998;325(9131):854 - 865.
10Yki- Jarvinen H, Kauppila M, Kujansuu E, et al. Comparison of insulin regimens in patients with non - insuhn - dependent diabetes mellitus[J]. N Engl J Med 1992;327(20) : 1426-1433.
7[2]Groop LC. Insulin resistance: the fundamental trigger of type 2 diabetes. Dbesity & Metabolism 1999; 1:2～ 9.
8[4]Matsumoto K, Miyake S, Yano M, et al. Glucose tolerance,insulirn secretion, and insulin seasitivity in nonobese and obese Japanese subjects. Diabetes care 1997;20:1562.
9[5]Belfiore F, Iannelo S, Volpicelli G, Insulin sensitivity indices calculated from basal and OGTT- Induced insulin, glucose,and FFA level. Mol Genet Metab 1998;63:134.
10[6]Wang My, Koyama K, Shimabukuro M, et al. ob - Rb gene transfer to leptin - resistant islets reverses diabetogenic phenotype. Proc Natl Acad Sei USA 1998;95:714～718.
